http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108431607-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L43-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108431607-B |
| titleOfInvention | Reagent diluent |
| abstract | The present invention relates to the field of diagnosis or prognosis. In particular, it relates to an immunoassay composition comprising (i) an amphiphilic macromolecule and (ii) an amphoteric copolymer based on (meth)acrylate monomers, some of which comprise phosphorylcholine groups. The disclosed compositions are particularly useful as stabilizers and/or blocking agents. |
| priorityDate | 2015-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.